Applied Molecular Transport Inc.

NasdaqCM:AMTI Stock Report

Market Cap: US$10.9m

Applied Molecular Transport Past Earnings Performance

Past criteria checks 0/6

Applied Molecular Transport's earnings have been declining at an average annual rate of -25.6%, while the Biotechs industry saw earnings growing at 17.4% annually.

Key information

-25.6%

Earnings growth rate

13.3%

EPS growth rate

Biotechs Industry Growth17.0%
Revenue growth raten/a
Return on equity-460.5%
Net Marginn/a
Last Earnings Update30 Sep 2023

Recent past performance updates

No updates

Recent updates

Here's Why We're A Bit Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation

Mar 07
Here's Why We're A Bit Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation

We're A Little Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate

Nov 13
We're A Little Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate

Applied Molecular Transport GAAP EPS of -$0.93

Aug 04

Companies Like Applied Molecular Transport (NASDAQ:AMTI) Could Be Quite Risky

Jul 27
Companies Like Applied Molecular Transport (NASDAQ:AMTI) Could Be Quite Risky

Applied Molecular Transport up 4% after hours on ulcerative colitis candidate data

Jul 05

Applied Molecular: Interesting Drug Delivery Approach For The GI Tract

May 03

We're Keeping An Eye On Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate

Apr 28
We're Keeping An Eye On Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate

We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely

Jan 08
We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely

We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely

Aug 29
We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely

Applied Molecular Transport (NASDAQ:AMTI) Is In A Good Position To Deliver On Growth Plans

Apr 05
Applied Molecular Transport (NASDAQ:AMTI) Is In A Good Position To Deliver On Growth Plans

Have Insiders Been Buying Applied Molecular Transport Inc. (NASDAQ:AMTI) Shares This Year?

Feb 11
Have Insiders Been Buying Applied Molecular Transport Inc. (NASDAQ:AMTI) Shares This Year?

Here's Why We're Not Too Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation

Dec 21
Here's Why We're Not Too Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation

Applied Molecular Transport reports Q3 results

Nov 12

Revenue & Expenses Breakdown
Beta

How Applied Molecular Transport makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:AMTI Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 230-7529-11
30 Jun 230-93307
31 Mar 230-1123227
31 Dec 220-1263745
30 Sep 220-1343764
30 Jun 220-1353764
31 Mar 220-1223558
31 Dec 210-1002941
30 Sep 210-892558
30 Jun 210-802027
31 Mar 210-721623
31 Dec 200-671354
30 Sep 200-551030
30 Jun 200-46746
31 Mar 200-38633
31 Dec 190-28424

Quality Earnings: AMTI is currently unprofitable.

Growing Profit Margin: AMTI is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AMTI is unprofitable, and losses have increased over the past 5 years at a rate of 25.6% per year.

Accelerating Growth: Unable to compare AMTI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AMTI is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-42.7%).


Return on Equity

High ROE: AMTI has a negative Return on Equity (-460.5%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.